Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Rate Hike Fears Dampen Market Sentiment
-
Bitcoin Whales Accumulated $3.5 Billion Worth of $BTC in 11 Weeks
-
United Natural Foods Plunges In Pre-market On Lower Profit Below View, Lowered Outlook
-
Peter Thiel’s Fund Cashed Out $1.8 Billion From Bitcoin Before 2022’s Crash
-
$BTC: Messina Group CEO Ready To Bet His Porsche That Bitcoin Is Going Back to $60K